Kennedy Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.8M | Sell |
834,155
-3,171
| -0.4% | -$108K | 0.5% | 39 |
|
|
2025
Q4 | $33.1M | Buy |
837,326
+410
| +0% | +$15K | 0.7% | 10 |
|
|
2025
Q3 | $29.5M | Buy |
836,916
+222,529
| +36% | +$7.67M | 0.65% | 12 |
|
|
2025
Q2 | $20.1M | Sell |
614,387
-17,741
| -3% | -$577K | 0.48% | 41 |
|
|
2025
Q1 | $20.4M | Sell |
632,128
-120,452
| -16% | -$4.47M | 0.49% | 39 |
|
|
2024
Q4 | $23M | Buy |
752,580
+172,648
| +30% | +$5.55M | 0.51% | 24 |
|
|
2024
Q3 | $16.3M | Buy |
579,932
+71,305
| +14% | +$1.76M | 0.36% | 58 |
|
|
2024
Q2 | $11.6M | Buy |
508,627
+281,434
| +124% | +$6.5M | 0.25% | 125 |
|
|
2024
Q1 | $6.91M | Buy |
227,193
+121,752
| +115% | +$4.08M | 0.14% | 242 |
|
|
2023
Q4 | $3.76M | Buy |
105,441
+18,362
| +21% | +$683K | 0.08% | 360 |
|
|
2023
Q3 | $3.81M | Buy |
87,079
+13,771
| +19% | +$672K | 0.09% | 340 |
|
|
2023
Q2 | $3.62M | Buy |
73,308
+38,298
| +109% | +$1.77M | 0.08% | 362 |
|
|
2023
Q1 | $1.45M | Sell |
35,010
-3,642
| -9% | -$151K | 0.04% | 444 |
|
|
2022
Q4 | $1.72M | Sell |
38,652
-2,210
| -5% | -$92.3K | 0.05% | 431 |
|
|
2022
Q3 | $1.6M | Sell |
40,862
-325
| -0.8% | -$14.9K | 0.05% | 444 |
|
|
2022
Q2 | $1.68M | Sell |
41,187
-388
| -0.9% | -$18.4K | 0.05% | 434 |
|
|
2022
Q1 | $2.73M | Sell |
41,575
-45,673
| -52% | -$2.96M | 0.06% | 404 |
|
|
2021
Q4 | $6.07M | Buy |
87,248
+39,357
| +82% | +$2.86M | 0.13% | 302 |
|
|
2021
Q3 | $3.33M | Sell |
47,891
-1,660
| -3% | -$128K | 0.07% | 414 |
|
|
2021
Q2 | $3.93M | Sell |
49,551
-15,764
| -24% | -$1.15M | 0.08% | 400 |
|
|
2021
Q1 | $4.28M | Sell |
65,315
-42,630
| -39% | -$2.63M | 0.09% | 400 |
|
|
2020
Q4 | $6.01M | Sell |
107,945
-3,341
| -3% | -$144K | 0.14% | 289 |
|
|
2020
Q3 | $4.44M | Buy |
111,286
+47,035
| +73% | +$1.99M | 0.13% | 309 |
|
|
2020
Q2 | $2.89M | Buy |
64,251
+26,172
| +69% | +$1.14M | 0.08% | 435 |
|
|
2020
Q1 | $1.28M | Buy |
+38,079
| New | +$1.37M | 0.05% | 527 |
|
|
2019
Q2 | – | Sell |
-242,951
| Closed | -$6.51M | – | 689 |
|
|
2019
Q1 | $6.51M | Sell |
242,951
-22,334
| -8% | -$678K | 0.15% | 251 |
|
|
2018
Q4 | $8.12M | Buy |
+265,285
| New | +$8.26M | 0.2% | 156 |
|
|
2015
Q2 | – | Sell |
-34,942
| Closed | -$716K | – | 727 |
|
|
2015
Q1 | $716K | Sell |
34,942
-90,202
| -72% | -$1.75M | 0.01% | 675 |
|
|
2014
Q4 | $2.5M | Sell |
125,144
-2,086
| -2% | -$35.8K | 0.05% | 540 |
|
|
2014
Q3 | $1.87M | Buy |
+127,230
| New | +$2.03M | 0.04% | 573 |
|
|
2014
Q1 | – | Sell |
-112,007
| Closed | -$2.09M | – | 743 |
|
|
2013
Q4 | $2.09M | Buy |
112,007
+52,693
| +89% | +$766K | 0.04% | 547 |
|
|
2013
Q3 | $651K | Buy |
+59,314
| New | +$585K | 0.01% | 683 |
|
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
Kennedy Capital Management's ATRC Position: Q1 2026 in Review
Kennedy Capital Management reduced its AtriCure (ATRC) stake by 0.38% in Q1 2026, selling an estimated $108K and leaving 834,155 shares worth $23.8M. The position accounts for 0.5% of the portfolio, ranked #39.
Kennedy Capital Management first reported a position in ATRC in Q3 2013 and has held it in 32 quarters since. The position peaked at $33.1M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Kennedy Capital Management held 834,155 shares of AtriCure worth $23.8M as of Q1 2026.
- Kennedy Capital Management sold 3,171 AtriCure shares in Q1 2026, an estimated $108K.
- AtriCure made up 0.5% of Kennedy Capital Management's portfolio in Q1 2026, its #39 holding.
- Kennedy Capital Management first reported a position in AtriCure in Q3 2013 and has held it in 32 quarters since.
- Kennedy Capital Management's AtriCure position peaked at $33.1M in Q4 2025.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.